TRAVERT 10% IN PLASTIC CONTAINER Drug Patent Profile
Which patents cover Travert 10% In Plastic Container, and when can generic versions of Travert 10% In Plastic Container launch?
Travert 10% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVERT 10% IN PLASTIC CONTAINER is invert sugar. There is one drug master file entry for this compound. Additional details are available on the invert sugar profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRAVERT 10% IN PLASTIC CONTAINER?
- What are the global sales for TRAVERT 10% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TRAVERT 10% IN PLASTIC CONTAINER?
Summary for TRAVERT 10% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAVERT 10% IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for TRAVERT 10% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVERT 10% IN PLASTIC CONTAINER | invert sugar | INJECTABLE;INJECTION | 016717-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
